[Catecholamines and their therapeutic implications].
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001337:Autonomic Agents / Q000145:classification; D002395:Catecholamines / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D011955:Receptors, Drug
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D001337:Autonomic Agents; D002395:Catecholamines; D011955:Receptors, Drug
Las catecolaminas y su influenciación terapéutica.